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http://www.herpesviridae.org/content/3/1/6RESEARCH Open AccessHSV-1-induced chemokine expression via
IFI16-dependent and IFI16-independent pathways
in human monocyte-derived macrophages
Stine Søby†, Rune R Laursen†, Lars Østergaard and Jesper Melchjorsen*Abstract
Background: Innate recognition is essential in the antiviral response against infection by herpes simplex virus
(HSV). Chemokines are important for control of HSV via recruitment of natural killer cells, T lymphocytes, and
antigen-presenting cells. We previously found that early HSV-1-mediated chemokine responses are not dependent
on TLR2 and TLR9 in human macrophages. Here, we investigated the role of the recently identified innate
IFN-inducible DNA receptor IFI16 during HSV-1 infection in human macrophages.
Methods: Peripheral blood mononuclear cells were purified from buffy coats and monocytes were differentiated to
macrophages. Macrophages infected with HSV-1 were analyzed using siRNA-mediated knock-down of IFI16 by
real-time PCR, ELISA, and Western blotting.
Results: We determined that both CXCL10 and CCL3 are induced independent of HSV-1 replication. IFI16 mediates
CCL3 mRNA accumulation during early HSV-1 infection. In contrast, CXCL10 was induced independently of IFI16.
Conclusions: Our data provide the first evidence of HSV-1-induced innate immune responses via IFI16 in human
primary macrophages. In addition, the data suggest that at least one additional unidentified receptor or innate
sensing mechanism is involved in recognizing HSV-1 prior to viral replication.
Keywords: Herpes simplex virus, Innate, IFI16, Chemokine, PRR, DNA, Macrophages, HumanIntroduction
Herpes simplex virus 1 (HSV-1) is a common human
pathogen that primarily gives rise to orofacial and ano-
genital infections, which are controlled by the immune
system in most cases. However, in newborns and im-
munocompromised individuals, the infection may be-
come systemic and have a fatal outcome. Furthermore,
HSV is a leading cause of virus-mediated encephalome-
ningitis [1,2]. Chemokines secreted at the site of infec-
tion are important for mobilization of effector cells to
the site of infection [3-5]. In mice, production of CXC
chemokine ligand 9 (CXCL9) and CXCL10 is important
for controlling genital infection with HSV. These che-
mokines mediate recruitment of T lymphocytes and nat-
ural killer (NK) cells [6], which are essential for* Correspondence: jesper.melchjorsen@ki.au.dk
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reproduction in any medium, provided the orrepression of HSV infection [7,8]. CC chemokine ligand
3 (CCL3) and CCL5 appear to be important regulators
of anti-HSV immunity, as mice deficient in their recep-
tor, CC chemokine receptor 5 (CCR5), are highly suscep-
tible to genital HSV-infection [9]. The present study was
designed to further evaluate chemokine expression and
innate sensing during HSV-infection in human primary
monocyte-derived macrophages.
Macrophages are sentinel cells in the innate immune
response [10], and human primary macrophages are po-
tent chemokine-producing cells important for control-
ling HSV infection [5,11,12]. Differentiated tissue
macrophages are derived from monocytes, recruited
from the blood. Macrophages display high phenotypic
and functional diversity due to differentiation stimuli
and the different environments in which they reside
[10,13]. High numbers of primary macrophages are not
easily purified from human tissues; therefore, most
experiments with human primary macrophages ared. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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blood monocytes.
During the last decade, multiple pattern recognition
receptors (PRRs) have been linked to innate recognition
of HSV infection, which has been thoroughly reviewed
elsewhere [14]. Briefly, cell surface Toll-like receptor 2
(TLR2) recognizes virion surface structures [15-17];
TLR3 recognizes virus-derived double-stranded RNA
(dsRNA) in human fibroblasts [18]; TLR9 mediates sens-
ing of HSV genomic DNA in endosomal compartments
in human and murine plasmacytoid dendritic cells
(pDCs) and murine macrophages [19-21]; and the RNA
helicase melanoma differentiation-associated gene 5
(MDA-5) senses virus-derived RNA in the cytoplasm of
human primary macrophages [22]. Finally, viral infection
may be recognized by membrane fusion events [23]. In
the present study, we investigated early innate recog-
nition mechanisms in human primary macrophages
with a focus on the recently discovered receptor for




For macrophage differentiation, leukocyte-rich buffy
coats were obtained from healthy blood donors (Skejby
Hospital Blood Bank). Peripheral blood mononuclear
cells were isolated and differentiated to macrophages, as
previously described [22]. PBMCs were purified from
freshly drawn blood from healthy donors. For all experi-
ments approval was given from the local ethical commit-
tee and informed written consent from all participating
subjects was obtained.
Virus preparations
The KOS strain of HSV-1 was used in this study. The
virus was produced as previously described [25]. Prior to
use, the virus was thawed and used as replication com-
petent virus or inactivate virus following exposure to UV
light for 5 min [25].
Small interfering RNA (siRNA) assays
After five days of cell culture in 6-well plates (Nunc,
Roskilde, Denmark), macrophages were transfected with
IFI16-specific siRNAs or control siRNA. Briefly, the cells
were subjected to transfection using 100 nM of IFI16
siRNAs (Stealth RNAi mix; HSS105205, HSS105206, and
HSS105207, Invitrogen, Glostrup Denmark) and recom-
mended controls (Stealth RNAi control, Invitrogen,
Glostrup, Denmark) combined with HiPerfect (Qiagen,
Hilden, Germany) according to the manufacturer’s
instructions. The cells were incubated with the
HiPerfect-siRNA mix for 4 hours at 37°C before the
media was changed to a fresh stock containing GM-CSF.Forty-eight hours after siRNA-transfections, the macro-
phages were used in infection experiments. Two hours
before infection, the macrophages were supplied with
fresh media without GM-CSF.
Stimulation experiments
Macrophage experiments were conducted after 7 days of
differentiation and PBMC experiments were conducted
after overnight culture of the cells. Cells were treated
with HSV-1 at a titer of 5 × 105 pfu/ml (Strain KOS,
MOI of 1). The TLR7/8-ligand R848 (InVivoGen, Tou-
louse, France) was used at a final concentration of 1 μg/ml.
Type I IFN, IFN-α (R&D Systems, Abingdon, England)
was used at the concentration 1000 U/ml. Lipofecta-
min2000 (invitrogen, Glostrup, DenmarK) was added to
the cells to a final concentration of 5 μl/ml. Total RNA
was harvested at 5 or 6 hours after infection using Trizol
and purified according to the manufacturer’s description
(Invitrogen, Glostrup, Denmark). Cell culture supernatants
were stored at −80°C until ELISA analysis.
Reverse transcription and real-time PCR
Total RNA was subjected to cDNA synthesis and subse-
quent real-time PCR analysis, as previously described
[22,26]. For the siRNA experiments, the mean of control
(untreated) siRNA treatments was used to quantify fold
induction for the other samples. The gene-specific
primers for IFI16, CCL3, CXCL10, and GAPDH used
(Primers synthesized by DNA Technology, Aarhus, Den-
mark): IFI16 Forward, TAG GCC CAG CTG AGA GCC
ATC C; IFI16 Reverse, TGA GGT CAC TCT GGG CAC
TGT CTT; CCL3 Forward, ACT TCA GAA GGA CAC
GGG C; CCL3 Reverse TGT AGC TGA AGC AGC
AGG C; CXCL10 forward, AGG AAC CTC CAG TCT
CAG CAC CA; CXCL10 Reverse, TGC TGA TGC AGG
TAC AGC GTA CA; GAPDH forward, CGA CCA CTT
TGT CAA GCT CA; GAPDH reverse, GGT GGT CCA
GGG GTC TTA CT.
ELISAs
CXCL10/IP-10 Cytoset ELISA kits (Invitrogen, Glostrup,
Denmark) were according to the manufacturer’s
protocol.
Whole cell extracts and Western Blotting
After 6 hours of stimulation whole cell extracts were
harvested essentially as described previously [26], the
only change being that a commercially available cell lysis
buffer was used (Biorad, Copenhagen, Denmark). To en-
sure equal loading of protein to the gels, protein was
quantified using a DC protein assay according to manu-
facturer’s description (Biorad, Copenhagen, Denmark).
For immunostains murine anti-IFI16 was used (clone
1GL, Santa Cruz Biotechnology, Santa Cruz, CA) at a
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lized as previously described [26].
Data analysis and statistics
Western blots were quantified using ImageJ. Statistical
analysis was performed using Student t-tests.
Results
Production of the chemokines CXCL10 and CCL3 during
early HSV-1 infection occurs independently from viral
replication
To evaluate whether early CCL3 and CXCL10 chemo-
kine production is dependent on viral replication, we
infected cells with replication-impaired UV-inactivated
virus. UV-inactivated HSV-1 was fully capable of indu-
cing CCL3 and CXCL10 expression (Figure 1A and B).
Overall, the induction of CCL3 and CXCL10 was slightly
elevated in cells treated with UV-inactivated virus com-
pared with cells infected with replication-competent
virus, indicating that viral replication products may in-
hibit CCL3 and CXCL10 expression. Thus, viral surface
structures or intracellular components, such as viral
DNA or tegument proteins, are directly recognized by
human macrophages
Expression of the innate DNA receptor IFI16 in human
macrophages
We have previously shown that CXCL10 production is
not dependent on TLR2 during HSV-1 infection and
that human primary macrophages are unresponsive to
TLR9 stimulation [22]. Therefore, we concentrated our
studies on IFI16, an intracellular DNA receptor recently
shown to mediate intracellular recognition of HSV-Figure 1 Virus replication-independent expression of CCL3 and
CXCL10 in HSV-1-infected human primary macrophages. Human
macrophages were infected with HSV-1 (KOS, MOI of 1) or
equivalent amount of UV-inactivated virus. A and B) After 6 hours of
infection total RNA was harvested and expression of CCL3 and
CXCL10 evaluated by RT-qPCR. Data depicted represent mean +/−
SD of three independent donors from one of two experiments
showing similar results. *, p<0.05 and **, p<0.01 (t-test).derived synthetic DNA in murine macrophages [24]. We
found that IFI16 is present in human primary macro-
phages and that type I IFN induced IFI16 protein accu-
mulation (Figure 2A). Looking at IFI16-induction caused
by other stimuli, we found that early HSV-1 infection
resulted only in a slight, approximately two-fold in-
crease, in IFI16 mRNA levels; while, the induction
mediated by UV-inactivated virus was roughly four-fold
(Figure 2B). In addition, the TLR7/8-activating ligand
R848 triggered a donor-dependent 2- to 8-fold increased
accumulation of IFI16 mRNA (Figure 2C). Therefore,
IFI16 is present and inducible in human primary
macrophages.Figure 2 IFI16 expression in human macrophages. A)
Macrophages were stimulated with IFN-α (1000 U/ml) for 6 hours
and intracellular levels of IFI16 were assessed by Western blotting. B
and C) Macrophages were stimulated with R848 (1 μg/ml) or
infected with HSV-1 or UV-inactivated HSV-1 (KOS, MOI of 1) for 6
hours before assessing IFI16 mRNA-levels by RT-qPCR. The Western
blot shown in A (lower panel) represents one of three donors
showing similar results and the quantified data (upper panel)
represents the mean +/−SD of the three donors from one
experiment. The data depicted in B and C represents mean +/− SD
of at least two donors of one of two independent experiments with
similar results. *, p<0.05 (t-test).
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chemokine mRNA accumulation
Using siRNA-mediated knock-down of IFI16, we assessed
the production of CCL3 and CXCL10 in response to
HSV-infection of human primary macrophages from two
to three independent donors in three separate experi-
ments. In all donors, there was 60 to 95% knock-down of
IFI16 at the mRNA level (Figure 3A) and protein levels
were also reduced (Figure 3B). As seen in Figure 3C, HSV-
1-induced accumulation of CCL3 mRNA is dependent onFigure 3 Chemokine mRNA accumulation during HSV-1
infection via IFI16-dependent and IFI16-independent
mechanism. Macrophages were transfected with siRNA targeting
IFI16 or control siRNA for 48 hours before infection with HSV-1 (KOS,
MOI of 1) or stimulation with IFN-α (1000 U/ml). Mock infections
were made as control. A) After 6 h, total RNA was harvested and
IFI16 mRNA-levels were assayed using RT-qPCR. B) IFI16 protein-
levels were evaluated by Western blotting in untreated
macrophages 48 hours after transfection with control siRNA and
IFI16 siRNA. C and D) Total RNA harvested at 6 hours post infection
was analyzed for expression of CCL3 and CXCL10 using RT-qPCR.
Results depicted represent one of four donors (A, C and D) and
three donors (B) with similar results. *, p<0.05 and **, p<0.01 (t-test).IFI16. In contrast, IFI16 knock-down resulted in increased
or unchanged CXCL10 expression during early HSV infec-
tion, suggesting that IFI16 is not required for CXCL10
expression (Figure 3D). The data suggest that CXCL10 is
either induced via recognition of virion components, such
as capsid or DNA, or via detection of the lipid membrane-
coated virus entering the cell. The latter seems plausible,
since we found CXCL10 was readily induced by lipid bind-
ing to both human PBMCs (Figure 4A) and human
primary macrophages (Figure 4B). In contrast, CCL3 was
not induced by Lipofectmine2000 in the macrophages
(data not shown), suggesting that CCL3 mRNA accumula-
tion is mediated via post-fusion steps.
Collectively, our data supports that the IFN-inducible
DNA receptor IFI16 is present and inducible in human
primary macrophages. Our experiments suggest that
early CCL3 and CXCL10 induction occurs indepen-
dently from virus replication, indicating direct recogni-
tion of virion structures or fusion events in human
macrophages. Additionally, our data show that accumu-
lation of CCL3 mRNA is dependent on the innate DNA
receptor IFI16 during early HSV-1 infection; whereas,
HSV-1 induction of CXCL10 proceeds via a yet unchar-
acterized pathway, possibly pertaining to viral fusion
events.Figure 4 Lipid-lipid interactions mediate CXCL10 induction in
human primary cells. PBMCs (A) and primary macrophages (B)
were treated with lipofectamin2000 at the concentration 5 μl/ml
and RNA was harvested at 5 hours and cell supernatants at 24 h.
RNA was analyzed by qRT-PCR and supernatants analyzed for
secreted CXCL10 using ELISA. The results in A and B represents
mean+/− SD of two donors from one of two experiments showing
similar results.
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Based on our findings here and previously [5,22], we
suggest that HSV-1 is recognized by intracellular sensors
present in the cytoplasm or the nucleus of human
macrophages. Moreover, we hypothesize that virus fu-
sion events result in expression of specific mediators of
innate immunity. Our data support that IFI16 plays a
role during early HSV-1 infection of human primary
macrophages. HSV-1 DNA released during early infec-
tion may be recognized by IFI16, resulting in expression
of CCL3 (Figure 3C); while, CXCL10 expression is
mediated via an IFI16-independent pathway (Figure 3D).
Furthermore, we found that IFI16 is upregulated by type
I IFN and by the nuclear factor kappa B (NF-κB)-activating
TLR7/8 agonist R848 (Figure 2A and C); yet, it is only
slightly upregulated by HSV-1 during very early infection
(Figure 2B).
UV-inactivated HSV-1 elicited a greater CCL3 and
CXCL10 response compared to infection with replica-
tion competent virus (Figure 1A and B); therefore, the
present data support previous findings suggesting that
viral replication products inhibit IFN and chemokine ex-
pression in human macrophages as well as other cells
[5]. For example, the viral protein ICP27 appears to har-
bor immune-modulatory capabilities, as demonstrated
by more potent stimulation of CXCL10 and other cyto-
kines in macrophages infected with a HSV-1 ICP27-
deletion mutant compared with infection with wild type
virus [5]. Evidence of immune-evasive activity has also
been shown for several other HSV proteins, including
ICP0, ICP34.5, Us11, vhs, and US3, which were reviewed
previously [27,28]. IFN-inducible IFI16 was more effec-
tively induced in macrophages infected with UV-
inactivated HSV-1 compared with replication competent
HSV, further supporting the notion that viral replication
products counteract IFN responses.
The first cytoplasmic DNA receptor for HSV DNA
was identified in 2007. The DNA-dependent activator of
IFN regulatory factors (DAI) has been shown to mediate
recognition of HSV DNA in a murine fibroblast cell line
[29]. Since the initial publications relating to DAI,
accumulating evidence has suggested additional DNA
receptors exist. Within the past two years, major break-
throughs have been achieved, and an increasing number
of DNA receptors have been associated with innate
sensing of HSV, including the pyrin and HIN domain-
containing protein (PYHIN) family member IFI16, which
recognizes HSV-1-derived DNA in murine macrophages
and Hela cells [24].
CCL3 mRNA accumulation was found to be
dependent on IFI16 (Figure 3C). However, IFI16 knock-
down did not consistently reduce CCL3 protein levels
after 20 h of infection (data not shown). Reasons for this
discrepancy between the mRNA and protein datainclude the following: i) CCL3 protein secretion may be
transcriptionally regulated by factors other than IFI16
during HSV-1 infection in monocyte-derived macro-
phages or ii) CCL3 induction at the later time point is
partly due to other virally induced factors, such as
induced TNF-α [30], which we have previously found to
be secreted 5 h after infection [5]. Therefore, studies
evaluating CCL3 mRNA and protein accumulation at
later stages during infection may be complicated by se-
cretion of other mediators and by the accumulation of
viral gene-products that selectively interfere with innate
immune responses. However, the observed early IFI16-
dependent CCL3 mRNA accumulation precedes the
HSV-1-induced secretion of cytokines [5]. Therefore, we
believe the CCL3 mRNA accumulation is mediated by
direct sensing of HSV-1 virions.
Very recent data suggest a multifunctional role for
IFI16 during HSV-1, HSV-2, and CMV infection. Studies
from Gariano et al. demonstrated that siRNA knock-
down of IFI16 enhanced viral replication [31], indicating
IFI16 is a restriction factor for herpes virus replication.
In theory, IFI16 could mediate innate recognition of
HSV-1, while restricting replication at the same time.
Thus, knock-down of IFI16 could enhance replication-
dependent innate responses. Our data showed a two-
to three-fold increased induction of CXCL10 in response
to HSV-1-infection when macrophages were subjected to
IFI16 knock-down (Figure 3D). Reduced IFI16 protein
levels might result in decreased competition for viral
DNA binding; thus, other DNA receptors able to
stimulate CXCL10 expression have greater access to
HSV-1 DNA not sequestered by IFI16. Another ex-
planation could be redundant systems leading to
CXCL10 mRNA accumulation: one dependent on
virus replication (possibly being sensitive to IFI16 in-
hibition) and one via a pre-replication step. Further
studies are necessary to determine whether IFI16 reg-
ulates mRNA accumulation and/or transcription or
IFI16 acts as an innate receptor, and whether IFI16
restricts HSV-1 replication in human primary cells
and/or sequesters viral DNA.
It should be noted that induction of CXCL10 may also
be mediated by fusion or membrane-membrane intera-
ctions between the virus and cell. Collins et al. showed
that HSV-1 replication is not required for induction of the
IFN-stimulated genes CXCl10 and ISG56 [32], which is
supported by our data showing replication-independent
CXCL10 induction (Figure 1B). Moreover, a very recent
study demonstrated that fusion events may indeed trigger
innate responses, including expression of CXCL10 [23].
Accordingly, we found that membrane-membrane inter-
actions induced CXCL10 in human primary macro-
phages and human peripheral blood mononuclear cells
(Figure 4A and B). We hypothesize that viral fusion
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IFI16-independent induction of CXCL10. Furthermore,
we found that CCL3 is not induced by lipofectamin2000,
suggesting that CCL3 mRNA accumulation is mediated
via post-entry steps involving IFI16.
A number of other potential DNA sensors that
recognize HSV-1 have been identified since this study was
completed. The helicases DDX41, DDX60, DHX9, and
DHX36 were identified as regulators of HSV-induced type
I IFN and cytokine responses [33-35]. Zhang Z. et al.
found that DDX41 mediates IFN-β, TNF-α, and IL-6
responses by recognizing viral DNA in the cytoplasm fol-
lowing HSV-1 infection in murine DCs [33]. Miyashita
et al. found that DDX60 binds dsRNA and dsDNA in the
cytoplasm and mediates induction of IFN-β and CXCL10
during HSV-1 infection in Hela cells; in addition, they
found DDX60 promotes RIG-I and MDA-5 signaling [34].
Therefore, it remains to be determined whether DDX60
senses the HSV-1 genome or rather enhances the RLR-
mediated signaling after HSV infection. Finally, Kim T.
et al. found that DHX9 mediates TNF-α expression and
DHX36 mediates IFN-α production in a human plasmacy-
toid cell line. In addition to the helicases, the DNA bind-
ing protein Ku70 was recently found to mediate type III
IFN responses in HEK293 cells after DNA was introduced
into the cells or cells were infected with HSV-2 [36].
Future investigations are necessary to further elucidate
the role of IFI16 and determine the following: i) whether
IFI16 functions as a primary innate receptor for HSV-1
DNA in human primary macrophages; ii) whether the
aforementioned helicases DDX41, DDX60, DHX9 and
DHX36, and Ku70 are sensors of viral DNA in human
primary cells, including human primary macrophages;
iii) which cellular responses these proteins regulate in
primary cells; iv) whether HSV infection is sensed by
DDX40, DDX41, DHX9, or DHX36 in human primary
cells, including human primary macrophages; v) whether
the specificity of DNA-induced innate responses is based
on involvement of specific signaling adaptors and/or rec-
ognition of specific DNA sequences or lengths of DNA;
vi) whether one of the newly identified DNA receptors
mediates expression of CXCL10; vii) whether lipid-lipid
interactions induce CXCL10/ISG expression in human
primary macrophages during early HSV-1 infection or
infection with other enveloped viruses; and viii) whether
IFI16 is a restriction factor of HSV-1 infection in human
primary cells.
Further details on the innate DNA receptors may pro-
vide important knowledge for the development of novel
DNA vaccine adjuvants, specifically targeting receptors
of interest. As proposed by A. Iwasaki, timed and
targeted cytokine and chemokine responses may facili-
tate an influx of cells necessary for efficient vaccine
responses in mucosal areas [37]. CXCL9 and CXCL10play an important role in regulating NK cell and T
lymphocyte influx to the site of infection and for control
of vaginal HSV infection [6]; therefore, modulated
production of specific chemokines may be imperative for
future vaccine adjuvant candidates [37]. CCL3 could be
important in terms of HSV clearance, as mice lacking
the CCL3 receptor CCR5 are highly susceptible to vagi-
nal HSV-2 infection [9]. In the context of vaccines, it is
of interest that intracellular delivery of DNA forming a
complex with lipids has yielded promising results in
guinea pigs, decreasing viral replication and the severity
of infection [38-40]. Based on the current knowledge,
lipid-delivered DNA may provide two independent in-
nate signals, one via lipid-interaction with the target cell
membrane and one from the DNA targeting a cytoplas-
mic or nuclear DNA receptor.
Further investigation is necessary to determine the role
of IFI16 and other DNA receptors in the development of
novel DNA vaccine adjuvants targeting the cytoplasm.
Furthermore, it remains to be determined whether DNA
adjuvants will improve HSV vaccines in humans. How-
ever, a detailed understanding of cytoplasmic/nuclear
DNA-host receptor interactions and the subsequent in-
nate responses generated may provide rationale for use
of delivering DNA to the cytoplasm or nucleus of cells
as a vaccine adjuvant or direct antiviral therapy.
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